← Leaderboards
Roy Curtiss
Washington University
$24,753,526
Attributed
$26,081,032
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,081,032 · 11
By mechanism
R01$23,971,252 · 8
U01$1,436,998 · 1
R21$422,125 · 1
R42$250,657 · 1
Top collaborators
- Josephine E Clark-Curtiss5 shared
- Aria Eshraghi1 shared
Most similar at Washington University
Same institution · by research overlap
- Eduardo A. Groisman$21,000,681
- Stephen Bradley Freedman$4,674,559
- David Schnadower$4,943,242
- Ali Hassan Ellebedy$14,119,121
- Richard K. Wilson$520,796,051
Others in their field
Top investigators on “Salmonella Vaccines”
- Daniel F. Hoft · Saint Louis University$27,270,253
- Marcelo B. Sztein · University Of Maryland Baltimore$22,566,745
- Stephen J McSorley · University Of California At Davis$12,511,867
- Marc K. Jenkins · University Of Minnesota Twin Cities$11,655,727
- Gary Fanger · Rise Therapeutics, Llc$10,892,234
- William Albert Blattner · University Of Maryland Baltimore$10,254,597
Research focus
Salmonella VaccinesSalmonella TyphimuriumAntigensRecombinantsVaccinesImmunityInfectionAttenuatedSafetyCytolysisDesign And ConstructionVaccine DevelopmentSeedsSalmonella TyphiPreventImmunizationAnimalsCessation Of LifeIn VivoLegal PatentProtocols DocumentationVaccine CandidateResearch StudyPathogen
Grant awards (60)
Salmonella-mediated delivery of Francisella type VI secretion system proteins as antigens to induce protective immunity$422,125
R21 · FY2025 · AI
Heterologous polysaccharide synthesis in attenuated Salmonella$350,553
R01 · FY2019 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$444,683
R01 · FY2018 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$444,683
R01 · FY2017 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$444,683
R01 · FY2016 · AI · contact PI
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents$1,007,282
R01 · FY2015 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$444,683
R01 · FY2015 · AI · contact PI
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents$1,025,685
R01 · FY2014 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$454,156
R01 · FY2014 · AI · contact PI
Salmonella Vaccines Against Bacterial Enteropathogens$437,073
R01 · FY2014 · AI · contact PI
Attenuated Live and Recombinant Yersinia Pestis Vaccines$377,438
R01 · FY2014 · AI · contact PI
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents$964,143
R01 · FY2013 · AI · contact PI
Salmonella Vaccines Against Bacterial Enteropathogens$410,849
R01 · FY2013 · AI · contact PI
Attenuated Live and Recombinant Yersinia Pestis Vaccines$354,791
R01 · FY2013 · AI · contact PI
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents$1,025,685
R01 · FY2012 · AI · contact PI
Salmonella Vaccines Against Bacterial Enteropathogens$437,073
R01 · FY2012 · AI · contact PI
Attenuated Live and Recombinant Yersinia Pestis Vaccines$377,438
R01 · FY2012 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$373,663
R01 · FY2012 · AI · contact PI
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents$1,026,895
R01 · FY2011 · AI · contact PI
Salmonella Vaccines Against Bacterial Enteropathogens$437,283
R01 · FY2011 · AI · contact PI
Attenuated Live and Recombinant Yersinia Pestis Vaccines$377,438
R01 · FY2011 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$373,663
R01 · FY2011 · AI · contact PI
Salmonella Vaccines Against Bacterial Enteropathogens$492,115
R01 · FY2010 · AI · contact PI
Attenuated Live and Recombinant Yersinia Pestis Vaccines$381,250
R01 · FY2010 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$377,438
R01 · FY2010 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$381,250
R01 · FY2009 · AI · contact PI
Attenuated Live and Recombinant Yersinia pestis Vaccines$594,217
R01 · FY2008 · AI · contact PI
Salmonella anti-influenza DNA & antigen delivery vaccine$590,554
R01 · FY2008 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$372,974
R01 · FY2008 · AI · contact PI
Salmonella anti-influenza DNA & antigen delivery vaccine$712,024
R01 · FY2007 · AI · contact PI
Attenuated Live and Recombinant Yersinia pestis Vaccines$588,958
R01 · FY2007 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$354,382
R01 · FY2007 · AI · contact PI
S. typhimiurium Vaccine Against Bacterial Enteropathogens$308,505
U01 · FY2007 · AI · contact PI
Salmonella anti-influenza DNA & antigen delivery vaccine$596,609
R01 · FY2006 · AI · contact PI
Attenuated Live and Recombinant Yersinia pestis Vaccines$589,785
R01 · FY2006 · AI · contact PI
Recombinant Attenuated Salmonella Vaccines for Humans$364,967
R01 · FY2006 · AI · contact PI
Molecular Genetic Analysis of Salmonella Pathogenicity$328,471
R01 · FY2006 · AI · contact PI
S. typhimiurium Vaccine Against Bacterial Enteropathogens$309,344
U01 · FY2006 · AI · contact PI
Attenuated Live and Recombinant Yersinia pestis Vaccines$540,020
R01 · FY2005 · AI
Recombinant Attenuated Salmonella Vaccines for Humans$373,750
R01 · FY2005 · AI
Molecular Genetic Analysis of Salmonella Pathogenicity$336,375
R01 · FY2005 · AI
S. typhimiurium Vaccine Against Bacterial Enteropathogens$308,459
U01 · FY2005 · AI
Salmonella anti-influenza DNA &antigen delivery vaccine$274,648
R01 · FY2005 · AI
Attenuated Live and Recombinant Yersinia pestis Vaccines$584,984
R01 · FY2004 · AI
Recombinant Attenuated Salmonella Vaccines for Humans$382,500
R01 · FY2004 · AI
ANTIGEN DELIVERY SYSTEM DESIGN FOR HOST DEFENSE ANALYSIS$327,250
R01 · FY2004 · DE
S. typhimiurium Vaccine Against Bacterial Enteropathogens$254,078
U01 · FY2004 · AI
Molecular Genetic Analysis of Salmonella Pathogenicity$183,098
R01 · FY2004 · AI
Molecular Genetic Analysis of Salmonella Pathogenicity$155,437
R01 · FY2004 · AI
S. typhimiurium Vaccine Against Bacterial Enteropathogens$52,108
U01 · FY2004 · AI
Molecular Genetic Analysis of Salmonella Pathogenicity$346,500
R01 · FY2003 · AI
ANTIGEN DELIVERY SYSTEM DESIGN FOR HOST DEFENSE ANALYSIS$327,250
R01 · FY2003 · DE
Recombinant Attenuated Salmonella Vaccines for Humans$215,587
R01 · FY2003 · AI
S. typhimiurium Vaccine Against Bacterial Enteropathogens$204,504
U01 · FY2003 · AI
Molecular Genetic Analysis of Salmonella Pathogenicity$361,807
R01 · FY2002 · AI
ANTIGEN DELIVERY SYSTEM DESIGN FOR HOST DEFENSE ANALYSIS$327,250
R01 · FY2002 · DE
ANTIGEN DELIVERY SYSTEM DESIGN FOR HOST DEFENSE ANALYSIS$327,427
R01 · FY2001 · DE
ANTIGEN DELIVERY SYSTEM DESIGN FOR HOST DEFENSE ANALYSIS$328,844
R01 · FY2000 · DE
MOLECULAR GENETIC ANALYSIS OF SALMONELLA PATHOGENICITY$263,691
R01 · FY2000 · AI
BIOLOGICAL CONTAINMENT OF LIVE BACTERIAL VACCINES$250,657
R42 · FY2000 · AI